期刊文献+

隐丹参酮与多奈哌齐合用对β-淀粉样蛋白诱导SH-SY5Y细胞凋亡的保护作用 被引量:3

Protective effect of combination of cryptotanshinone and donepezil on amyloid-β protein induced apoptosis in SH-SY5Ycells
下载PDF
导出
摘要 目的观察隐丹参酮(CTS)与多奈哌齐(DON)合用对β-淀粉样蛋白(Aβ)损伤SH-SY5Y细胞的保护作用,并探讨其可能的机制。方法体外培养SH-SY5Y细胞,建立阿尔茨海默病(AD)细胞模型,采用MTT法检测细胞存活率,Hoechst荧光染色检测细胞凋亡,Western blot检测Bcl-2和Bax的表达。结果 CTS、DON及联合用药均能明显减轻Aβ对SH-SY5Y细胞的损伤,提高细胞的存活率,显著上调Bc1-2蛋白表达,减少Bax蛋白表达,抑制细胞凋亡。CTS与DON合用其抑制细胞凋亡的效果显著强于CTS与DON单用,差异有统计学意义(P<0.05)。结论 CTS与DON合用对Aβ损伤SH-SY5Y细胞有协同保护作用,其机制可能与协同调节凋亡相关基因Bcl-2蛋白家族的表达有关。 Objective To investigate the relationship between aggrecan and YKL-40 in knee articular cartilage of Sprague-Daw-lay(SD) rats with osteoarthritis (OA) .Methods Fifty-six healthy SD rats were randomly divided into 7 groups ,8 cases per group . The one side of knee joint was randomly selected for performing the anterior cruciate ligment transection (ACLT) and establishing the OA model .The rats in one group were randomly killed on the day of operation and at postoperative 0 ,2 ,4 ,8 ,12 ,16 ,20 weeks . The femoral condyle cartilage samples at different time periods in the operated side were collected for conducting safranin O /fast green staining and HE staining .Meanwhile ,the OA pathological grade was made out according to the modified Mankin scale .The expression of aggrecan and YKL-40 in the cartilage with different stages of OA were analyzed by the immunohistochemistry meth-od ,and the status of expression were measured by average optical density (AOD) .The correlation between aggrecan and YKL-40 was analyzed .Results With the aggravation of OA ,the expression of aggrecan was gradually reduced and the expression of YKL-40 was gradually increased .The differences during the early ,middle and late phases of OA had statistical significance (P&lt;0 .05) . The expression of aggrecan was negatively correlated with the expression of YKL-40(P&lt;0 .05) .Conclusion The level of aggrecan is gradually reduced with the aggravation of OA .Aggrecan is negatively correlated with the YKL-40 level ,which may reflect the dedifferentiation degree of joint chondrocyte to some extent .
出处 《重庆医学》 CAS CSCD 北大核心 2014年第10期1211-1213,共3页 Chongqing medicine
基金 广东省中医药强省基金项目(20111257)
关键词 阿尔茨海默病 隐丹参酮 多奈哌齐 细胞凋亡 Alzheimer disease cryptotanshinone donepezil apoptosis
  • 相关文献

参考文献16

  • 1Landau SM,Mintun MA,Joshi AD,et al. Amyloid deposi- tion, hypometabolism, and longitudinal cognitive decline [J]. Ann Neurol,2012,72(4) :578-586.
  • 2Hardy J, Selkoe DJ. The amyloid hypothesis of Alzhei- merfs disease: progress and problems on the road to ther- apeutics[J]. Science, 2002,297 (5580) : 353-356.
  • 3Zhou L, Zuo Z, Chow MS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use[J]. J Clin Pharmacol, 2005,45 ( 12 ) : 1345-1359.
  • 4Kim DH, Jeon SJ, Jung JW, et al. Tanshinone congeners improve memory impairments induced by scopolamine on passive avoidance tasks in mice [J]. Eur J Pharmacol, 2007,574(2/3) : 140-147.
  • 5赵瑾,王延江,张涛,贾晓军,许志强,张猛,周华东.安理申治疗阿尔茨海默病的临床研究[J].重庆医学,2008,37(7):716-717. 被引量:7
  • 6郭静静,廖红.阿尔茨海默病治疗药物的研究进展[J].中国药科大学学报,2010,41(5):395-400. 被引量:22
  • 7Boffito M, Fox J,Bowman C, et al. Safety,immunogenicity and efficacy assessment of HIV immunotherapy in a multi centre, double-blind, randomised, Placebo-controlled Phase Ib human trial[J]. Vaccine, 2013,31 (48) : 5680- 5686.
  • 8Cornelli U. Treatment of Alzheimer's disease with a cho- linesterase inhibitor combined with antioxidants[J]. Neu- rodegener Dis, 2010,7 (1/2/3) : 193-202.
  • 9Tariot PN, Farlow MR, Grossberg GT, et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized con- trolled trial[J]. JAMA, 2004,291(3) : 317-324.
  • 10Creeley CE,Wozniak DF, Nardi A, et al. Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain [J]. Neurobiol Aging, 2008,29(2) : 153-167.

二级参考文献63

  • 1张德芹,张建军,钟赣生,王景霞,胡素敏,高学敏.芪蓝糖脂宁胶囊对糖尿病合并高脂血症大鼠肝细胞凋亡及Bax、Bcl-2蛋白表达的影响[J].中华中医药杂志,2005,20(4):211-213. 被引量:24
  • 2廖国超,聂爱华,肖军海,钟武,李松.β-分泌酶抑制剂的研究进展[J].中国药物化学杂志,2006,16(6):373-379. 被引量:9
  • 3金桂芳,梅寒芳,杨红.阿尔茨海默病的发病机制及药物治疗进展[J].广东药学院学报,2006,22(6):697-700. 被引量:14
  • 4Brookmeyer R, Johnson E,Ziegler-Graham K,et al. Forecasting the global burden of Alzheimer' s disease [ J ]. Alzheimers Dement,2007,3 ( 3 ) : 186 - 191.
  • 5Neugroschl J, Sano M. Current treatment and recent clinical research in Alzheimer's disease [J]. Mt Sinai J Med, 2010,77 (1):3 -16.
  • 6Giacobini E. Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer' disease [ J ]. J Neural Transm Suppl,2002, ( 62 ) : 181 - 187.
  • 7Nieoullon A. Acetylcholinesterase inhibitors in Alzheimer's disease : further comments on their mechanisms of action and therapeutic consequences [ J ]. Psychol Neuropsychiatr Vieil, 2010,8 (2) :123 -131.
  • 8Mangialasche F, Solomon A, Winblad B,et al. Alzheimer's disease : clinical trials and drug development [ J ]. Lancet Neurol, 2010,9(7) :702 -716.
  • 9Thomas SJ,Grossberg GT. Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias[ J]. Clin Interv Aging,2009,4:367 - 377.
  • 10Geldenhuys WJ,Van der Schyf CJ. The serotonin 5-HT6 receptor:a viable drug target for treating cognitive deficits in Alzheimer's disease[J]. Expert Rev Neurother,2009,9 (7) : 1 073 - 1 085.

共引文献134

同被引文献18

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部